Abiopharma

Director Woods Eugene A. 🟢 acquired 186 shares (1 derivative) of JOHNSON & JOHNSON (JNJ) Transaction Date: Dec 09, 2025 | Filing ID: 000217

New Form DEFA14A - Xenetic Biosciences, Inc. Filed: 2025-12-11 AccNo: 0001683168-25-009077 Size: 32 KB

Vanda Pharmaceuticals Announces Participation in the J.P. Morgan Healthcare Conference

📋 Atlas Venture Fund X, L.P. (Director) plans to sell 5K shares of Kymera Therapeutics, Inc. (at $87.81 each, total $450K) Filed: Dec 11, 2025 | ID: 000089

(99% Neutral) LIPOCINE INC. (LPCN) Files Form 8-K

New Form D - Oncotelic Therapeutics, Inc. Filed: 2025-12-11 AccNo: 0001493152-25-027270 Size: 7 KB

(99% Neutral) Xenetic Biosciences, Inc. (XBIO) Announces Business Combination

(99% Neutral) VolitionRx Limited (VNRX) Announces Executive Changes

(99% Neutral) MODULAR MEDICAL, INC. (MODD) Files Form 8-K

WILLS STEPHEN T 🟢 acquired 1.9K shares (3 derivative) of PALATIN TECHNOLOGIES INC (PTN) at $362.50 Transaction Date: Dec 09, 2025 | Filing ID: 027272

Director Morris Arlene 🟢 acquired 4.8K shares (2 derivative) of PALATIN TECHNOLOGIES INC (PTN) at $21.38 Transaction Date: Dec 09, 2025 | Filing ID: 027271

Director SPANA CARL 🟢 acquired 2.2K shares (3 derivative) of PALATIN TECHNOLOGIES INC (PTN) at $362.50 Transaction Date: Dec 09, 2025 | Filing ID: 027269

New Form 424B1 - NextCure, Inc. Filed: 2025-12-11 AccNo: 0001104659-25-120346 Size: 199 KB

Director DUNTON ALAN W 🟢 acquired 4.4K shares (2 derivative) of PALATIN TECHNOLOGIES INC (PTN) at $21.38 Transaction Date: Dec 09, 2025 | Filing ID: 027267

Director PRENDERGAST JOHN K A 🟢 acquired 5.8K shares (2 derivative) of PALATIN TECHNOLOGIES INC (PTN) at $21.38 Transaction Date: Dec 09, 2025 | Filing ID: 027268